Financial Architects (New Jersey)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-75
Closed -$1K 1383
2019
Q1
$1K Hold
75
﹤0.01% 1379
2018
Q4
$3K Hold
75
﹤0.01% 1199
2018
Q3
$3K Hold
75
﹤0.01% 1297
2018
Q2
$2K Hold
75
﹤0.01% 1218
2018
Q1
$3K Hold
75
﹤0.01% 1296
2017
Q4
$2K Hold
75
﹤0.01% 1413
2017
Q3
$2K Hold
75
﹤0.01% 1413
2017
Q2
$2K Hold
75
﹤0.01% 1430
2017
Q1
$2K Hold
75
﹤0.01% 1452
2016
Q4
$2K Hold
75
﹤0.01% 1291
2016
Q3
$3K Hold
75
﹤0.01% 1258
2016
Q2
$11K Buy
+75
New +$8.6K ﹤0.01% 953

Other funds holding NVAX

Financial Architects (New Jersey)'s NVAX Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Novavax (NVAX) in Q2 2019, closing a stake of 75 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in NVAX in Q2 2016 and held it in 12 quarters. The position peaked at $11K in Q2 2016. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 75 Novavax shares in Q2 2019, an estimated $1K.
  • Financial Architects (New Jersey) first reported a position in Novavax in Q2 2016 and held it in 12 quarters.
  • Financial Architects (New Jersey)'s Novavax position peaked at $11K in Q2 2016.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.